Article
Integrative analysis of metabolome and gut microbiota in diet-induced hyperlipidemic rats treated with berberine compounds.
Journal of translational medicine - 5 Aug 2016
Li Meng, Shu Xiangbing, Xu Hanchen, Zhang Chunlei, Yang Lili, Zhang Li, Ji Guang
Abstract excerpt
BACKGROUND: Hyperlipidemia is a major component of metabolic syndrome, and often predicts cardiovascular diseases. We developed a new therapeutic agent berberine compounds (BC), consisting of berberine, oryzanol and vitamin B6, and determined their anti-hyperlipidemia activity and underlying mechanisms. METHODS: Male Wistar rats were fed a high fat diet (HFD) to induce hyperlipidemia, and then given BC orally for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
